Andreika L, Vankeviciene K, Plioplyte M, Bitinaityte M, Rudaitis V
Medicina (Kaunas). 2023; 59(5).
PMID: 37241226
PMC: 10224237.
DOI: 10.3390/medicina59050995.
Cai W, Ge W, Zhang J, Xie S, Wu D, Hu H
Therap Adv Gastroenterol. 2021; 14:17562848211036453.
PMID: 34733354
PMC: 8558787.
DOI: 10.1177/17562848211036453.
Sugiyama K, Shiraishi K, Sato M, Nishibori R, Nozawa K, Kitagawa C
J Gastrointest Cancer. 2020; 52(3):947-951.
PMID: 32918273
DOI: 10.1007/s12029-020-00516-7.
Thomas K, Voros B, Meadows-Taylor M, Smeltzer M, Griffin R, Boudreaux J
Cancers (Basel). 2020; 12(1).
PMID: 31947598
PMC: 7017154.
DOI: 10.3390/cancers12010206.
Chen M, Chou W, Hsiao C, Jiang S, Tsai H, Liu Y
Oncologist. 2019; 25(5):e782-e788.
PMID: 31852810
PMC: 7216444.
DOI: 10.1634/theoncologist.2019-0490.
Metastatic mixed adenoneuroendocrine carcinoma of the liver successfully resected by hepatic trisectionectomy following chemotherapy: A case report.
Sato O, Tsuchikawa T, Yamada T, Sato D, Nakanishi Y, Asano T
Clin Case Rep. 2019; 7(3):491-496.
PMID: 30899479
PMC: 6406150.
DOI: 10.1002/ccr3.1968.
Current best practice in the management of neuroendocrine tumors.
Tsoli M, Chatzellis E, Koumarianou A, Kolomodi D, Kaltsas G
Ther Adv Endocrinol Metab. 2019; 10:2042018818804698.
PMID: 30800264
PMC: 6378464.
DOI: 10.1177/2042018818804698.
Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
Fields A, Lu P, Vierra B, Hu F, Irani J, Bleday R
Ann Surg Oncol. 2019; 26(4):1127-1133.
PMID: 30706232
PMC: 6402804.
DOI: 10.1245/s10434-019-07203-3.
Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
Thomas K, Voros B, Boudreaux J, Thiagarajan R, Woltering E, Ramirez R
Oncologist. 2019; 24(8):1076-1088.
PMID: 30635447
PMC: 6693730.
DOI: 10.1634/theoncologist.2018-0604.
Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum.
Gul-Klein S, Sinn M, Jurmeister P, Biebl M, Weiss S, Rau B
SAGE Open Med Case Rep. 2018; 6:2050313X18758816.
PMID: 29568525
PMC: 5858677.
DOI: 10.1177/2050313X18758816.
Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.
Petersenn S, Koch C
Rev Endocr Metab Disord. 2018; 18(4):373-378.
PMID: 29480376
DOI: 10.1007/s11154-018-9442-7.
Mixed Adenoneuroendocrine Carcinoma of the Gastroesophageal Junction: A Rare Find.
Ambesh P, Weissbrot J, Ratner S, Sinha A, Patti R, Balderacchi J
J Investig Med High Impact Case Rep. 2018; 5(4):2324709617750180.
PMID: 29318164
PMC: 5753953.
DOI: 10.1177/2324709617750180.
Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K, Karakatsanis A, Hessman O, Stuart H, Welin S, Janson E
JAMA Oncol. 2017; 4(2):183-189.
PMID: 29049611
PMC: 5838704.
DOI: 10.1001/jamaoncol.2017.3326.
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach.
Werner R, Weich A, Higuchi T, Schmid J, Schirbel A, Lassmann M
Theranostics. 2017; 7(6):1489-1498.
PMID: 28529632
PMC: 5436508.
DOI: 10.7150/thno.18754.
Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors.
Milione M, Maisonneuve P, Pellegrinelli A, Pusceddu S, Centonze G, Dominoni F
Endocrine. 2016; 57(3):512-517.
PMID: 27905048
DOI: 10.1007/s12020-016-1180-6.
Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception.
Morais M, Pinho A, Marques A, Lopes J, Duarte A, da Silva P
Case Rep Surg. 2016; 2016:7684364.
PMID: 27525153
PMC: 4976167.
DOI: 10.1155/2016/7684364.
Small bowel neuroendocrine tumors: From pathophysiology to clinical approach.
Xavier S, Rosa B, Cotter J
World J Gastrointest Pathophysiol. 2016; 7(1):117-24.
PMID: 26909234
PMC: 4753177.
DOI: 10.4291/wjgp.v7.i1.117.
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma.
Bongiovanni A, Riva N, Ricci M, Liverani C, La Manna F, De Vita A
Onco Targets Ther. 2015; 8:3613-9.
PMID: 26664145
PMC: 4671803.
DOI: 10.2147/OTT.S91971.
Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues.
Brieau B, Lepere C, Walter T, Lecomte T, Guimbaud R, Manfredi S
Medicine (Baltimore). 2015; 94(42):e1864.
PMID: 26496341
PMC: 4620767.
DOI: 10.1097/MD.0000000000001864.
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
Kaemmerer D, Trager T, Hoffmeister M, Sipos B, Hommann M, Sanger J
Oncotarget. 2015; 6(29):27566-79.
PMID: 26259237
PMC: 4695009.
DOI: 10.18632/oncotarget.4491.
